In these roles, he has determined metabolomic signatures and pathway perturbations associated with human disease (e.g., osteoarthritis), nutrient deficiencies in wild type and knockout animal models (e.g., folate), and cellular response to anti-cancer agents. Dr. Rushing’s career interests lie in using omics techniques to study how nutrients and other compounds from the diet can be used to enhance the efficacy of drugs or mitigate against their adverse effects.